We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Panel Votes New Studies for Two Leukemia Drugs
Advisory Panel Votes New Studies for Two Leukemia Drugs
September 4, 2009
The FDA’s Oncology Drugs Advisory Committee voted 9–3 to recommend that Genzyme conduct a randomized, controlled trial of leukemia drug Clolar before the agency considers expanding the drug’s indications to include elderly patients.